R, G., M, B., E, L., E, B., A, V., MF, L., . . . F, G. (2014). Laboratory aspirin resistance reversibility in diabetic patients: A pilot study using different pharmaceutical formulations. Cardiovascular drugs and therapy, 28(4), 323. https://doi.org/10.1007/s10557-014-6536-7
Chicago Style (17th ed.) CitationR, Grimaldi, et al. "Laboratory Aspirin Resistance Reversibility in Diabetic Patients: A Pilot Study Using Different Pharmaceutical Formulations." Cardiovascular Drugs and Therapy 28, no. 4 (2014): 323. https://doi.org/10.1007/s10557-014-6536-7.
MLA (9th ed.) CitationR, Grimaldi, et al. "Laboratory Aspirin Resistance Reversibility in Diabetic Patients: A Pilot Study Using Different Pharmaceutical Formulations." Cardiovascular Drugs and Therapy, vol. 28, no. 4, 2014, p. 323, https://doi.org/10.1007/s10557-014-6536-7.